LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer

Published:2020-06 Issue: Volume:17 Page:361-370
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Hu Ziming,Zheng Xiaohu,Jiao Defeng,Zhou Yonggang,Sun Rui,Wang Baolong,Tian Zhigang,Wei Haiming

Funder

Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference36 articles.

1. Management of non-small-cell lung cancer: recent developments;Reck;Lancet,2013

2. NR4A transcription factors limit CAR T cell function in solid tumours;Chen;Nature,2019

3. Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors;Morello;Cancer Discov.,2016

4. Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo;Ye;Exp. Ther. Med.,2019

5. Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies;Beatty;Cancer Immunol. Res.,2014

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19;Frontiers in Immunology;2024-09-06

2. Emerging Targets and Therapeutics in Immuno-Oncology: Insights from Landscape Analysis;Journal of Medicinal Chemistry;2024-05-24

3. The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors;Advances in Molecular Oncology;2024-04-05

4. Biomarkers for predicting efficacy of chimeric antigen receptor T cell therapy and their detection methods;iLABMED;2024-02-16

5. Roles of tissue-resident immune cells in immunotherapy of non-small cell lung cancer;Frontiers in Immunology;2023-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3